240 related articles for article (PubMed ID: 22349819)
1. REV3L 3'UTR 460 T>C polymorphism in microRNA target sites contributes to lung cancer susceptibility.
Zhang S; Chen H; Zhao X; Cao J; Tong J; Lu J; Wu W; Shen H; Wei Q; Lu D
Oncogene; 2013 Jan; 32(2):242-50. PubMed ID: 22349819
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in lipid metabolism related miRNA binding sites and risk of metabolic syndrome.
Ye Q; Zhao X; Xu K; Li Q; Cheng J; Gao Y; Du J; Shi H; Zhou L
Gene; 2013 Oct; 528(2):132-8. PubMed ID: 23911300
[TBL] [Abstract][Full Text] [Related]
3. Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site.
Brewster BL; Rossiello F; French JD; Edwards SL; Wong M; Wronski A; Whiley P; Waddell N; Chen X; Bove B; ; Hopper JL; John EM; Andrulis I; Daly M; Volorio S; Bernard L; Peissel B; Manoukian S; Barile M; Pizzamiglio S; Verderio P; Spurdle AB; Radice P; Godwin AK; Southey MC; Brown MA; Peterlongo P
Hum Mutat; 2012 Dec; 33(12):1665-75. PubMed ID: 22753153
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility.
Lin Y; Nie Y; Zhao J; Chen X; Ye M; Li Y; Du Y; Cao J; Shen B; Li Y
Carcinogenesis; 2012 Dec; 33(12):2377-83. PubMed ID: 22971574
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer.
Xiong F; Wu C; Chang J; Yu D; Xu B; Yuan P; Zhai K; Xu J; Tan W; Lin D
Cancer Res; 2011 Aug; 71(15):5175-81. PubMed ID: 21676885
[TBL] [Abstract][Full Text] [Related]
6. MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis.
Wang K; Li J; Guo H; Xu X; Xiong G; Guan X; Liu B; Li J; Chen X; Yang K; Bai Y
Carcinogenesis; 2012 Nov; 33(11):2147-54. PubMed ID: 22859270
[TBL] [Abstract][Full Text] [Related]
7. A common polymorphism in the 3'UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population.
Hu Z; Miao X; Ma H; Wang X; Tan W; Wei Q; Lin D; Shen H
Lung Cancer; 2005 Apr; 48(1):11-7. PubMed ID: 15777967
[TBL] [Abstract][Full Text] [Related]
8. REV3L single nucleotide variants lead to increased susceptibility towards non-small cell lung cancer in the population of Jammu and Kashmir.
Jamwal RS; Mahajan N; Bhat GR; Bhat A; Shah R; Verma S; Sharma M; Sharma B; Qadri RA; Kumar R; Bhat A
Cancer Epidemiol; 2021 Dec; 75():102047. PubMed ID: 34655923
[TBL] [Abstract][Full Text] [Related]
9. G-A variant in miR-200c binding site of EFNA1 alters susceptibility to gastric cancer.
Li Y; Nie Y; Cao J; Tu S; Lin Y; Du Y; Li Y
Mol Carcinog; 2014 Mar; 53(3):219-29. PubMed ID: 23065816
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in genes encoding for polymerase ζ subunits associates with breast cancer risk, tumour characteristics and survival.
Varadi V; Bevier M; Grzybowska E; Johansson R; Enquist K; Henriksson R; Butkiewicz D; Pamula-Pilat J; Tecza K; Hemminki K; Lenner P; Försti A
Breast Cancer Res Treat; 2011 Aug; 129(1):235-45. PubMed ID: 21455670
[TBL] [Abstract][Full Text] [Related]
11. A variant in the CHEK2 promoter at a methylation site relieves transcriptional repression and confers reduced risk of lung cancer.
Zhang S; Lu J; Zhao X; Wu W; Wang H; Lu J; Wu Q; Chen X; Fan W; Chen H; Wang F; Hu Z; Jin L; Wei Q; Shen H; Huang W; Lu D
Carcinogenesis; 2010 Jul; 31(7):1251-8. PubMed ID: 20462940
[TBL] [Abstract][Full Text] [Related]
12. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study.
Tseng RC; Hsieh FJ; Shih CM; Hsu HS; Chen CY; Wang YC
Cancer; 2009 Jul; 115(13):2939-48. PubMed ID: 19408343
[TBL] [Abstract][Full Text] [Related]
13. A functional polymorphism of PON1 interferes with microRNA binding to increase the risk of ischemic stroke and carotid atherosclerosis.
Liu ME; Liao YC; Lin RT; Wang YS; Hsi E; Lin HF; Chen KC; Juo SH
Atherosclerosis; 2013 May; 228(1):161-7. PubMed ID: 23497787
[TBL] [Abstract][Full Text] [Related]
14. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in a hsa-let-7 binding site in RAD52 is associated with breast cancer susceptibility.
Jiang Y; Qin Z; Hu Z; Guan X; Wang Y; He Y; Xue J; Liu X; Chen J; Dai J; Jin G; Ma H; Wang S; Shen H
Carcinogenesis; 2013 Mar; 34(3):689-93. PubMed ID: 23188672
[TBL] [Abstract][Full Text] [Related]
16. Association of DNA repair gene XRCC1 and lung cancer susceptibility among nonsmoking Chinese women.
Yin J; Vogel U; Ma Y; Qi R; Wang H
Cancer Genet Cytogenet; 2009 Jan; 188(1):26-31. PubMed ID: 19061777
[TBL] [Abstract][Full Text] [Related]
17. A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer.
Hao B; Miao X; Li Y; Zhang X; Sun T; Liang G; Zhao Y; Zhou Y; Wang H; Chen X; Zhang L; Tan W; Wei Q; Lin D; He F
Oncogene; 2006 Jun; 25(25):3613-20. PubMed ID: 16652158
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility.
Lu J; Zhang S; Chen D; Wang H; Wu W; Wang X; Lei Y; Wang J; Qian J; Fan W; Hu Z; Jin L; Shen H; Huang W; Wei Q; Lu D
FASEB J; 2009 Oct; 23(10):3459-69. PubMed ID: 19541747
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic insights into the link between a polymorphism of the 3'UTR of the SLC7A1 gene and hypertension.
Yang Z; Kaye DM
Hum Mutat; 2009 Mar; 30(3):328-33. PubMed ID: 19067360
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms involved in the miR-218-LAMB3 pathway and susceptibility of cervical cancer, a case-control study in Chinese women.
Zhou X; Chen X; Hu L; Han S; Qiang F; Wu Y; Pan L; Shen H; Li Y; Hu Z
Gynecol Oncol; 2010 May; 117(2):287-90. PubMed ID: 20163849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]